The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis C virus infection. 1997

T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
Department of Pathology, Saga Medical School, Japan.

BACKGROUND An etiologically important role has been suggested for hepatitis C virus (HCV) infection in the development of B-cell non-Hodgkin's lymphoma (NHL). HCV has been recognized as the major cause of non-A, non-B chronic hepatitis throughout the world. Moreover, the occurrence of primary splenic malignant lymphoma (PSML) has been demonstrated in patients with chronic liver disease. METHODS In this study, the authors describe three patients with PSML. The clinical, histologic, and immunohistochemical features of the lymphomas were studied. Clonal immunoglobulin heavy chain gene rearrangement was investigated by polymerase chain reaction. RESULTS All three cases of PSML were detected by imaging studies performed in routine follow-up of cases of chronic liver disease associated with HCV infection. Macronodular lesions were found in the three spleens; two of them were of normal weight and another was moderately enlarged. The former two were the smallest PSMLs reported to date. The histology was B-cell NHL in all cases. All 3 patients were alive after splenectomy with an average follow-up of 51.7 months (range, 35-74 months). CONCLUSIONS HCV infection may play an etiologic role in the development of splenic B-cell lymphoma. The long survival of the patients in this study may have been due to early splenectomy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D013160 Splenic Neoplasms Tumors or cancer of the SPLEEN. Cancer of Spleen,Spleen Cancer,Cancer of the Spleen,Neoplasms, Splenic,Spleen Neoplasms,Splenic Cancer,Cancer, Spleen,Cancer, Splenic,Cancers, Spleen,Cancers, Splenic,Neoplasm, Spleen,Neoplasm, Splenic,Neoplasms, Spleen,Spleen Cancers,Spleen Neoplasm,Splenic Cancers,Splenic Neoplasm
D015326 Gene Rearrangement, B-Lymphocyte, Heavy Chain Ordered rearrangement of B-lymphocyte variable gene regions of the IMMUNOGLOBULIN HEAVY CHAINS, thereby contributing to antibody diversity. It occurs during the first stage of differentiation of the IMMATURE B-LYMPHOCYTES. B-Cell Heavy Chain Gene Rearrangement,B-Lymphocyte Heavy Chain Gene Rearrangement,B-Lymphocyte Mu Chain Gene Rearrangement,B Cell Heavy Chain Gene Rearrangement,B Cell Mu Chain Gene Rearrangement,B Lymphocyte Heavy Chain Gene Rearrangement,B Lymphocyte Mu Chain Gene Rearrangement
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016403 Lymphoma, Large B-Cell, Diffuse Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation. Diffuse Large B-Cell Lymphoma,Diffuse, Large B-Cell, Lymphoma,Histiocytic Lymphoma, Diffuse,Lymphoma, Histiocytic, Diffuse,Diffuse Large-Cell Lymphoma,Histiocytic Lymphoma,Large Lymphoid Lymphoma, Diffuse,Large-Cell Lymphoma, Diffuse,Lymphoma, Diffuse Large-Cell,Lymphoma, Histiocytic,Lymphoma, Large Cell, Diffuse,Lymphoma, Large Lymphoid, Diffuse,Lymphoma, Large-Cell, Diffuse,Diffuse Histiocytic Lymphoma,Diffuse Histiocytic Lymphomas,Diffuse Large B Cell Lymphoma,Diffuse Large Cell Lymphoma,Diffuse Large-Cell Lymphomas,Histiocytic Lymphomas,Large Cell Lymphoma, Diffuse,Lymphoma, Diffuse Histiocytic,Lymphoma, Diffuse Large Cell

Related Publications

T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
January 2001, Abdominal imaging,
T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
January 1999, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna,
T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
May 2002, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
September 2006, Leukemia & lymphoma,
T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
February 2011, BMJ case reports,
T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
March 1995, Internal medicine (Tokyo, Japan),
T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
March 2016, The Tokai journal of experimental and clinical medicine,
T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
December 2011, Journal of Crohn's & colitis,
T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
November 2001, Internal medicine (Tokyo, Japan),
T Satoh, and T Yamada, and S Nakano, and O Tokunaga, and S Kuramochi, and T Kanai, and H Ishikawa, and T Ogihara
July 2010, Journal of clinical pathology,
Copied contents to your clipboard!